Rapporteurs: Barbara Fain, Kristin Viswanathan, Bruce M. Altevogt
This study was supported by contracts between the National Academy of Sciences and the American College of Emergency Physicians; the American Hospital Association; the American Medical Association; the American Nurses Association; the Association of State and Territorial Health Officials; the Centers for Disease Control and Prevention (Contract No. 200-2005-13434 TO #6); the Department of the Army (Contract No. W81XWH-08-P-0934); the Department of Health and Human Services’ National Institutes of Health (Contract No. N01-OD-4-2139 TO #198 and TO #244); the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (Contract Nos. HHSP233200900680P, HHS P23320042509X1); the Department of Homeland Security’s Federal Emergency Management Agency (Contract No. HSFEHQ-08-P-1800); the Department of Homeland Security’s Office of Health Affairs (Contract No. HSHQDC-07-C-00097); the Department of Transportation’s National Highway Traffic Safety Administration (Contract No. DTNH22-10-H-00287); the Department of Veterans Affairs (Contract No. V101(93)P-2136 TO #10); the Emergency Nurses Association; the National Association of Chain Drug Stores; the National Association of County and City Health Officials; the National Association of Emergency Medical Technicians; the Pharmaceutical Research and Manufacturers of America; the Robert Wood Johnson Foundation; and the United Health Foundation.
IOM (Institute of Medicine). 2012. Public engagement on facilitating access to antiviral medications and information in an influenza pandemic: Workshop series summary. Washington, DC: The National Academies Press.
The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the project.
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.